Table 3.
Univariate analysis results (HFMD stage I-II versus control; *HFMD III-IV versus HFMD stage I-II).
| Index | Effect size (β) | 95% CI | p-value | |||
|---|---|---|---|---|---|---|
| Age | 0.233 | *1.234 | 0.140-0.388 | *0.829-1.835 | <10-4 | *0.299 |
| Gender | ||||||
| Female | Reference: 1 | − | − | |||
| Male | 2.714 | *1.842 | 1.274-5.782 | *0.495-6.848 | 0.0096 | *0.362 |
| WBC count | 1.180 | *1.1093 | 1.035-1.346 | *0.995-1.237 | 0.014 | *0.062 |
| HB level | −0.001 | *0.995 | −0.001-0.001 | *0.943-1.049 | 0.999 | *0.855 |
| PLT count | 0.996 | *1.008 | 0.990-1.0008 | *1.001-1.015 | 0.097 | *0.020 |
| ALB level | 0.999 | *0.999 | 0.00001-1.0001 | *0.868-1.149 | 0.999 | *0.985 |
| ALT level | 0.001 | *0.973 | −0.001-0.001 | *0.914-1.036 | 0.999 | *0.392 |
| AST level | −0.001 | *0.976 | −0.001-0.001 | *0.933-1.021 | 0.999 | *0.289 |
| Scr level | 0.001 | *0.978 | −0.001-0.001 | *0.9001-1.062 | 0.999 | *0.597 |
| Ca level | −0.001 | *0.126 | −0.001-0.001 | *0.0012-13.103 | 0.999 | *0.382 |
| P lebel | 0.001 | *0.725 | −0.001-0.001 | *0.067-7.842 | 0.999 | *0.791 |
| Mg level | −0.001 | *0.002 | −0.001-0.001 | *0.00001-0.505 | 0.998 | *0.028 |
HFMD: hand, foot, and mouth disease, WBC: white blood cell, HB: hemoglobulin, PLT: platelet, ALB: albumin, ALT: alanine aminotransferase, AST: aspartate aminotransferase, Scr: serum creatinine, Ca: calcium, P: phosphorus, Mg: magnesium.